A recent study reveals many websites selling compounded versions of weight-loss drugs do not inform users of risks, often ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Eli Lilly & Co. ( LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026.
In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
This practice is not approved by the U.S. Food and Drug Administration (FDA). "Health care clinicians do not typically ...
With rumours about celebrities using semaglutide drugs like Ozempic for quick weight loss the question remains Are these anti ...
In a rare move, the FDA recommended a minimum of 5% weight-loss for drug developers seeking to establish the efficacy of ...
Global health highlights include a court pausing a generic version of a heart drug, Novo Nordisk's weight loss trial success, ...